Red Door Wealth Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Red Door Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 14, 2020	SELL	$27.75 - $36.3 $41,625 - $54,449	-1,500 Closed	0 $0
Q2 2020 Jul 07, 2020	SELL	$27.21 - $41.0 $13,605 - $20,500	-500 Reduced 25.0%	1,500 $41,000
Q1 2020 Apr 20, 2020	BUY	$19.54 - $38.85 $39,080 - $77,700	2,000 New	2,000 $59,000

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.16B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Red Door Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Red Door Wealth Management, LLC with notifications on news.